|
"Mechanisms of Damage-Induced Homologous Recombination"
|
5R01CA079827-09
|
$232,412
|
ENGELWARD, BEVIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-04
|
$381,417
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
5K08CA137153-02
|
$163,080
|
Collisson, Eric
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A novel combination therapy for the treatment of Pancreatic adenocarcinoma
|
1R03CA149857-01A1
|
$74,250
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A Novel ROS Controlling Kinase
|
5R21CA135164-02
|
$167,857
|
FRIEDMAN, EILEEN
|
UPSTATE MEDICAL UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant Glycosylation Signature in Pancreatic Cancer
|
1R21CA149772-01A1
|
$188,000
|
Pan, Sheng
|
UNIVERSITY OF WASHINGTON
|
|
Academic Training in Medical Oncology
|
3T32CA009297-28S1
|
$66,919
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Academic Training in Medical Oncology
|
5T32CA009297-28
|
$316,308
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ACOSOG Central Specimen Bank
|
3U24CA114736-05S2
|
$167,529
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
1U10CA149950-01A1
|
$1,300,000
|
SLOAN, JEFF
|
MAYO CLINIC
|
|
ACOSOG Competing Renewal
|
2U10CA076001-15
|
$2,940,780
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
3U10CA076001-15S1
|
$1,198,072
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ADAM17 in pancreatic cancer and pancreatitis
|
1R01CA159222-01
|
$395,872
|
CRAWFORD, HOWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A
|
1R33CA155586-01A1
|
$340,860
|
Porter, Marc
|
UNIVERSITY OF UTAH
|
|
Alternative splicing in Ras transformed cells
|
ZIA BC 011397
|
$130,717
|
Luo, Ji
|
CCR (NCI)
|
|
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
|
5R01CA129967-03
|
$297,887
|
MITCHELL, ROBERT
|
UNIVERSITY OF LOUISVILLE
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-05
|
$435,619
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-09
|
$334,263
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Animal model of Pancreatic Cancer
|
ZIA BC 011186
|
$203,845
|
Hussain, S. Perwez
|
CCR (NCI)
|
|
Anti-tumor Activity of Sugar Analogs via Blocking Glycolysis vs Glycosylation
|
5R01CA037109-22
|
$332,956
|
LAMPIDIS, THEODORE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
|
5R01CA067267-17
|
$424,249
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Antibody bead array technology for diagnosis of pre-invasive pancreatic cancer
|
1R21CA158267-01A1
|
$195,913
|
Allen, Peter
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S1
|
$139,575
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S2
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-33
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Aspects of MUC13 Mucin in Cancer
|
5R01CA142736-02
|
$306,622
|
Chauhan, Subhash
|
SANFORD RESEARCH/USD
|
|
Assessing pancreatic cancer susceptibility to ceramide-mediated cell death.
|
5R21CA143755-02
|
$198,950
|
Cabot, Myles
|
JOHN WAYNE CANCER INSTITUTE
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$170,206
|
Avital, Itzhak
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$828,679
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
ATDC Function in Human Pancreatic Adenocarcinoma
|
5R01CA131045-04
|
$308,573
|
SIMEONE, DIANE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer
|
5U01CA128437-05
|
$277,966
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
|
5R01CA132734-04
|
$304,127
|
Vile, Richard
|
MAYO CLINIC
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biological Activity of Ras Oncogenes
|
5R01CA042978-25
|
$356,891
|
DER, CHANNING
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
|
5U01CA141468-03
|
$470,159
|
ENGLEMAN, EDGAR G.
|
STANFORD UNIVERSITY
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$195,669
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers for the Early Detection of Pancreatic Cancer
|
5U01CA111302-07
|
$597,485
|
KILLARY, ANN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Black/White PHS Study
|
ZIA CP010136-00430
|
$66,493
|
Silverman, Debra
|
DCEG (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$255,308
|
Avital, Itzhak
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,020,703
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Camptothecin Analogs for Cancer Therapy
|
5R44CA125871-03
|
$392,344
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
Cancer Center Core Support Grant
|
2P30CA016086-35
|
$6,839,993
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-35S1
|
$250,000
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-35S2
|
$74,653
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-40
|
$3,854,331
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-36S1
|
$107,856
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-36S2
|
$47,026
|
DEPINHO, RONALD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|